tiprankstipranks
Rapid7 (RPD)
NASDAQ:RPD
US Market
Want to see RPD full AI Analyst Report?

Rapid7 (RPD) Blogger Opinions & Sentiment

854 Followers

Blogger Sentiment

Bearish: 85.71%
Sector Average
Bearish
RPD Blogger sentiment is based on 7 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the General sector.

Blogger Article Distribution

ArticleDistribution
42% SeekingAlpha
28% Zacks
14% Investing
16% Others
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Rapid7 (RPD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks
Fortinet (FTNT) Upgraded by Morgan Stanley Ahead of Earnings Season
GuruFocus
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

A Small Opportunity In Rapid7
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any
Blogger Name
Blogger Rank
Blog
Date
Blogger Sentiment​
Article
Follow

FAQ

What do Seeking Alpha bloggers think of RPD?
Seeking Alpha’s Pan Research has a Bearish Sentiment.
    What do Motley Fool contributors think of RPD?
    Currently there's no blogger sentiment for RPD.
    What Is RPD’s Blogger Sentiment?
    RPD’s Blogger Sentiment is Bearish.
      What was the most recent blogger prediction for RPD?
      The most recent blogger prediction for RPD was made by Zacks Equity Research, who was Bearish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the General sector
          ALMUAeluma, Inc.
          VGVenture Global, Inc. Class A
          TTANServiceTitan, Inc. Class A
          APOApollo Global Management
          IBRXImmunityBio